Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ORCHID PHARMA vs PROCTER & GAMBLE HEALTH - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ORCHID PHARMA PROCTER & GAMBLE HEALTH ORCHID PHARMA/
PROCTER & GAMBLE HEALTH
 
P/E (TTM) x 65.1 39.0 167.1% View Chart
P/BV x 6.6 16.0 41.0% View Chart
Dividend Yield % 0.0 5.1 -  

Financials

 ORCHID PHARMA   PROCTER & GAMBLE HEALTH
EQUITY SHARE DATA
    ORCHID PHARMA
Mar-24
PROCTER & GAMBLE HEALTH
Jun-24
ORCHID PHARMA/
PROCTER & GAMBLE HEALTH
5-Yr Chart
Click to enlarge
High Rs1,3595,640 24.1%   
Low Rs3714,640 8.0%   
Sales per share (Unadj.) Rs161.5693.5 23.3%  
Earnings per share (Unadj.) Rs18.7121.1 15.5%  
Cash flow per share (Unadj.) Rs25.3137.6 18.4%  
Dividends per share (Unadj.) Rs0260.00 0.0%  
Avg Dividend yield %05.1 0.0%  
Book value per share (Unadj.) Rs230.6319.1 72.3%  
Shares outstanding (eoy) m50.7216.60 305.5%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x5.47.4 72.2%   
Avg P/E ratio x46.142.5 108.7%  
P/CF ratio (eoy) x34.237.4 91.5%  
Price / Book Value ratio x3.816.1 23.3%  
Dividend payout %0214.7 0.0%   
Avg Mkt Cap Rs m43,87285,323 51.4%   
No. of employees `000NANA-   
Total wages/salary Rs m6962,152 32.4%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m8,19411,513 71.2%  
Other income Rs m311156 199.2%   
Total revenues Rs m8,50511,669 72.9%   
Gross profit Rs m1,1082,858 38.8%  
Depreciation Rs m332274 121.3%   
Interest Rs m1677 2,324.4%   
Profit before tax Rs m9192,733 33.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-31723 -4.3%   
Profit after tax Rs m9512,010 47.3%  
Gross profit margin %13.524.8 54.5%  
Effective tax rate %-3.426.5 -12.8%   
Net profit margin %11.617.5 66.5%  
BALANCE SHEET DATA
Current assets Rs m7,9089,306 85.0%   
Current liabilities Rs m2,6006,253 41.6%   
Net working cap to sales %64.826.5 244.3%  
Current ratio x3.01.5 204.4%  
Inventory Days Days50298 16.8%  
Debtors Days Days871271 322.0%  
Net fixed assets Rs m7,63110,735 71.1%   
Share capital Rs m507166 305.5%   
"Free" reserves Rs m11,1875,131 218.0%   
Net worth Rs m11,6955,297 220.8%   
Long term debt Rs m1,2040-   
Total assets Rs m15,53920,041 77.5%  
Interest coverage x6.5380.6 1.7%   
Debt to equity ratio x0.10-  
Sales to assets ratio x0.50.6 91.8%   
Return on assets %7.210.1 71.5%  
Return on equity %8.137.9 21.4%  
Return on capital %8.451.7 16.3%  
Exports to sales %80.50-   
Imports to sales %30.469.6 43.6%   
Exports (fob) Rs m6,594NA-   
Imports (cif) Rs m2,4898,013 31.1%   
Fx inflow Rs m6,5945,421 121.6%   
Fx outflow Rs m2,7058,013 33.8%   
Net fx Rs m3,889-2,592 -150.0%   
CASH FLOW
From Operations Rs m1,2602,283 55.2%  
From Investments Rs m-3,120-69 4,541.9%  
From Financial Activity Rs m1,670-4,181 -40.0%  
Net Cashflow Rs m-190-1,967 9.7%  

Share Holding

Indian Promoters % 69.8 0.0 -  
Foreign collaborators % 0.0 51.8 -  
Indian inst/Mut Fund % 20.2 21.5 94.3%  
FIIs % 1.9 6.6 29.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 30.2 48.2 62.6%  
Shareholders   36,363 54,792 66.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ORCHID PHARMA With:   DIVIS LABORATORIES    SUN PHARMA    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on Orchid Pharma vs Procter & Gamble Health

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Orchid Pharma vs Procter & Gamble Health Share Price Performance

Period Orchid Pharma Procter & Gamble Health S&P BSE HEALTHCARE
1-Day 2.77% -0.20% 0.70%
1-Month 22.29% 0.09% -0.77%
1-Year 157.13% -1.16% 42.87%
3-Year CAGR 56.07% 0.70% 20.14%
5-Year CAGR 142.64% 3.78% 26.11%

* Compound Annual Growth Rate

Here are more details on the Orchid Pharma share price and the Procter & Gamble Health share price.

Moving on to shareholding structures...

The promoters of Orchid Pharma hold a 69.8% stake in the company. In case of Procter & Gamble Health the stake stands at 51.8%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Orchid Pharma and the shareholding pattern of Procter & Gamble Health.

Finally, a word on dividends...

In the most recent financial year, Orchid Pharma paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of 0.0%.

Procter & Gamble Health paid Rs 260.0, and its dividend payout ratio stood at 214.7%.

You may visit here to review the dividend history of Orchid Pharma, and the dividend history of Procter & Gamble Health.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Trades Higher | Nifty Above 23,450 | Info Edge & SJVN Jump 5% Sensex Today Trades Higher | Nifty Above 23,450 | Info Edge & SJVN Jump 5%(10:30 am)

Asian markets traded higher on Friday, following the overnight rally on Wall Street, and the release of economic data in the region.